Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Ho Carole, Directeur Médical. Director active across 2 companies, notably Denali Therapeutics Inc.. In total, 32 filings have been published. Breakdown: 0 buy · 24 sells. Total volume traded: €1.9m. History available since 19 August 2021. The latest transaction was disclosed on 12 August 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Ho Carole
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Ho Carole is Directeur Médical. She is associated with Denali Therapeutics Inc. as Chief Medical Officer and with Royalty Pharma plc as Director. She has 32 filings in total, and across the recent filings tracked, all are sales, for EUR 1904601 between 2021-08-23 and 2025-08-14.
